|

SHR-3045 Injection Placebo Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Guangdong Hengrui Pharmaceutical Co., Ltd1

Indications

  • Moderate to Severe Active Rheumatoid Arthritis1
  • Arthritis1

Other1 trial

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.